

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 7.25245277 |
| 2 | cytidine metabolic process (GO:0046087) | 7.25245277 |
| 3 | cytidine catabolic process (GO:0006216) | 7.25245277 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.47530000 |
| 5 | DNA deamination (GO:0045006) | 6.43200883 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.26889938 |
| 7 | negative regulation of T cell apoptotic process (GO:0070233) | 5.90809169 |
| 8 | regulation of activation of Janus kinase activity (GO:0010533) | 5.36704788 |
| 9 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.14979221 |
| 10 | negative regulation by host of viral transcription (GO:0043922) | 5.09059830 |
| 11 | regulation of T cell chemotaxis (GO:0010819) | 4.94865946 |
| 12 | positive regulation of T cell chemotaxis (GO:0010820) | 4.94865946 |
| 13 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.70934666 |
| 14 | T cell migration (GO:0072678) | 4.70721425 |
| 15 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.69920680 |
| 16 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 4.62075570 |
| 17 | actin nucleation (GO:0045010) | 4.58471603 |
| 18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.58009415 |
| 19 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.48506786 |
| 20 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.47831558 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.47257577 |
| 22 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.34028047 |
| 23 | eosinophil chemotaxis (GO:0048245) | 4.30639079 |
| 24 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.29985581 |
| 25 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.22034714 |
| 26 | negative regulation of stress fiber assembly (GO:0051497) | 4.19575532 |
| 27 | glycine transport (GO:0015816) | 4.18247100 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 4.16711197 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.08192871 |
| 30 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.05019459 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02545398 |
| 32 | negative regulation of cell killing (GO:0031342) | 4.02545398 |
| 33 | positive regulation of defense response to virus by host (GO:0002230) | 4.00067830 |
| 34 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.99311752 |
| 35 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.99311752 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 3.96869306 |
| 37 | macrophage chemotaxis (GO:0048246) | 3.94932762 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.92888069 |
| 39 | positive regulation of cell killing (GO:0031343) | 3.92497816 |
| 40 | regulation of T cell apoptotic process (GO:0070232) | 3.92114403 |
| 41 | regulation of chronic inflammatory response (GO:0002676) | 3.89085583 |
| 42 | eosinophil migration (GO:0072677) | 3.87203665 |
| 43 | regulation of cell killing (GO:0031341) | 3.81089118 |
| 44 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.78625449 |
| 45 | negative T cell selection (GO:0043383) | 3.72796584 |
| 46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69327085 |
| 47 | positive regulation of translational initiation (GO:0045948) | 3.68502777 |
| 48 | regulation of interleukin-8 secretion (GO:2000482) | 3.62846931 |
| 49 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.62659885 |
| 50 | monocyte chemotaxis (GO:0002548) | 3.60888328 |
| 51 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57556107 |
| 52 | lymphocyte chemotaxis (GO:0048247) | 3.56051121 |
| 53 | regulation of T cell migration (GO:2000404) | 3.54104066 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.51521035 |
| 55 | positive regulation of lymphocyte migration (GO:2000403) | 3.50679502 |
| 56 | negative thymic T cell selection (GO:0045060) | 3.50555737 |
| 57 | chemokine-mediated signaling pathway (GO:0070098) | 3.42538635 |
| 58 | negative regulation of leukocyte apoptotic process (GO:2000107) | 3.41231444 |
| 59 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.41119740 |
| 60 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.40988375 |
| 61 | negative regulation of viral genome replication (GO:0045071) | 3.33779179 |
| 62 | positive regulation of T cell migration (GO:2000406) | 3.33446488 |
| 63 | thymic T cell selection (GO:0045061) | 3.32827309 |
| 64 | response to gravity (GO:0009629) | 3.32076519 |
| 65 | sequestering of actin monomers (GO:0042989) | 3.30780522 |
| 66 | positive T cell selection (GO:0043368) | 3.29927853 |
| 67 | cellular defense response (GO:0006968) | 3.26297032 |
| 68 | positive regulation of interleukin-4 production (GO:0032753) | 3.23993984 |
| 69 | negative regulation of viral transcription (GO:0032897) | 3.18058556 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 3.16448003 |
| 71 | regulation of macrophage chemotaxis (GO:0010758) | 3.14073733 |
| 72 | regulation of lymphocyte migration (GO:2000401) | 3.14005842 |
| 73 | positive regulation of T cell mediated immunity (GO:0002711) | 3.13767987 |
| 74 | response to interleukin-15 (GO:0070672) | 3.12152425 |
| 75 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11895512 |
| 76 | T cell costimulation (GO:0031295) | 3.08652770 |
| 77 | metallo-sulfur cluster assembly (GO:0031163) | 3.06313518 |
| 78 | iron-sulfur cluster assembly (GO:0016226) | 3.06313518 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 3.05590835 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 3.05469479 |
| 81 | lymphocyte costimulation (GO:0031294) | 3.04750153 |
| 82 | negative regulation of telomere maintenance (GO:0032205) | 3.04272239 |
| 83 | regulation of T cell mediated immunity (GO:0002709) | 3.02395892 |
| 84 | negative regulation of B cell apoptotic process (GO:0002903) | 3.02110919 |
| 85 | lymphocyte migration (GO:0072676) | 3.02107506 |
| 86 | regulation of lymphocyte apoptotic process (GO:0070228) | 3.01959187 |
| 87 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.01491327 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.99713088 |
| 89 | neutrophil activation (GO:0042119) | 2.96977691 |
| 90 | mast cell activation involved in immune response (GO:0002279) | 2.95131737 |
| 91 | mast cell degranulation (GO:0043303) | 2.95131737 |
| 92 | cellular response to exogenous dsRNA (GO:0071360) | 2.94808099 |
| 93 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.93572227 |
| 94 | modulation by host of symbiont transcription (GO:0052472) | 2.92278254 |
| 95 | modulation by host of viral transcription (GO:0043921) | 2.92278254 |
| 96 | cytolysis (GO:0019835) | 2.90919969 |
| 97 | positive regulation of tolerance induction (GO:0002645) | 2.90108225 |
| 98 | interferon-gamma production (GO:0032609) | 2.88108470 |
| 99 | regulation of calcium-mediated signaling (GO:0050848) | 2.86561990 |
| 100 | regulation of mononuclear cell migration (GO:0071675) | 2.86476459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.71135568 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.28767636 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.71246436 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.43887982 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.04541492 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.78131458 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.32871322 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05327476 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.03225110 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96437509 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.82989634 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74748795 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54119835 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.40022662 |
| 15 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.37885738 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.32258496 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.23766105 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13660099 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12134386 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.02570988 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00108239 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.92251886 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 1.85798227 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81771500 |
| 25 | GATA3_26560356_Chip-Seq_TH2_Human | 1.79480634 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.78712189 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78595218 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78162642 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.77149844 |
| 30 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75911372 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.73130716 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69426389 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65140992 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62099057 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60263657 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59881909 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59844327 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.57330399 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.52158110 |
| 40 | P300_27268052_Chip-Seq_Bcells_Human | 1.51015614 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50593727 |
| 42 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.42816863 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42786489 |
| 44 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.39555915 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38354582 |
| 46 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37934450 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37855332 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.35825785 |
| 49 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.34945096 |
| 50 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33490603 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32361152 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25530141 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24507791 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24497459 |
| 55 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.23137697 |
| 56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20165379 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.18166335 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17017459 |
| 59 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16586185 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16491291 |
| 61 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15007265 |
| 62 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.14014150 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10145151 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10018494 |
| 65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08759226 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07970860 |
| 67 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07368844 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.07011275 |
| 69 | GATA3_26560356_Chip-Seq_TH1_Human | 1.06905128 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05338618 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05299070 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05271943 |
| 73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03516300 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03266464 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01841093 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99575181 |
| 77 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99348981 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98892161 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96577012 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95942779 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94541478 |
| 82 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93367553 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92760883 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92730973 |
| 85 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92517511 |
| 86 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.90457889 |
| 87 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.89561858 |
| 88 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88046963 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86263563 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85784127 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85168552 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84803565 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83296606 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83282172 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82611764 |
| 96 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.82224121 |
| 97 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81555181 |
| 98 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81348145 |
| 99 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.81274496 |
| 100 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.78442912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.40490022 |
| 2 | MP0004147_increased_porphyrin_level | 3.33913741 |
| 3 | MP0009785_altered_susceptibility_to | 3.05422304 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.02492767 |
| 5 | MP0005083_abnormal_biliary_tract | 2.99580566 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.86000770 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.83202839 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.80002633 |
| 9 | MP0002723_abnormal_immune_serum | 2.53124826 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.50012767 |
| 11 | MP0001819_abnormal_immune_cell | 2.42982572 |
| 12 | MP0001800_abnormal_humoral_immune | 2.42176767 |
| 13 | MP0005025_abnormal_response_to | 2.36060458 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.32024762 |
| 15 | MP0005387_immune_system_phenotype | 2.31705905 |
| 16 | MP0001790_abnormal_immune_system | 2.31705905 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.09676419 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.09632800 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.02552792 |
| 20 | MP0003436_decreased_susceptibility_to | 1.99038596 |
| 21 | MP0006082_CNS_inflammation | 1.95643795 |
| 22 | MP0002398_abnormal_bone_marrow | 1.92024424 |
| 23 | MP0003866_abnormal_defecation | 1.89160184 |
| 24 | MP0001905_abnormal_dopamine_level | 1.83903888 |
| 25 | MP0003045_fibrosis | 1.83836379 |
| 26 | MP0000685_abnormal_immune_system | 1.81586975 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.79545074 |
| 28 | MP0000716_abnormal_immune_system | 1.78780826 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 1.70066633 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.68401248 |
| 31 | MP0004134_abnormal_chest_morphology | 1.65239641 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.61199438 |
| 33 | MP0002722_abnormal_immune_system | 1.60696077 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.56942073 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.50436571 |
| 36 | MP0003011_delayed_dark_adaptation | 1.47554952 |
| 37 | MP0002419_abnormal_innate_immunity | 1.42697391 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.39850431 |
| 39 | MP0002429_abnormal_blood_cell | 1.39570594 |
| 40 | MP0004142_abnormal_muscle_tone | 1.38891644 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.35741922 |
| 42 | MP0002102_abnormal_ear_morphology | 1.33909994 |
| 43 | MP0002006_tumorigenesis | 1.33907388 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.33049743 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.32118084 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.23513918 |
| 47 | MP0001542_abnormal_bone_strength | 1.22914875 |
| 48 | MP0001853_heart_inflammation | 1.22866550 |
| 49 | MP0002405_respiratory_system_inflammati | 1.22073665 |
| 50 | MP0003880_abnormal_central_pattern | 1.21700725 |
| 51 | MP0003878_abnormal_ear_physiology | 1.20585002 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.20585002 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.14823476 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.13869227 |
| 55 | MP0003448_altered_tumor_morphology | 1.12420283 |
| 56 | MP0008469_abnormal_protein_level | 1.11573886 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.10564164 |
| 58 | MP0009763_increased_sensitivity_to | 1.09415179 |
| 59 | MP0001919_abnormal_reproductive_system | 1.09414296 |
| 60 | MP0001984_abnormal_olfaction | 1.08844270 |
| 61 | MP0003693_abnormal_embryo_hatching | 1.05989109 |
| 62 | MP0008872_abnormal_physiological_respon | 1.05100388 |
| 63 | MP0003137_abnormal_impulse_conducting | 1.03610537 |
| 64 | MP0000372_irregular_coat_pigmentation | 1.02255645 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.01775929 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98297599 |
| 67 | MP0001661_extended_life_span | 0.98025211 |
| 68 | MP0001188_hyperpigmentation | 0.96780201 |
| 69 | MP0001533_abnormal_skeleton_physiology | 0.96580572 |
| 70 | MP0004947_skin_inflammation | 0.90789549 |
| 71 | MP0002736_abnormal_nociception_after | 0.90480298 |
| 72 | MP0001764_abnormal_homeostasis | 0.90194269 |
| 73 | MP0005166_decreased_susceptibility_to | 0.89611385 |
| 74 | MP0005389_reproductive_system_phenotype | 0.88599218 |
| 75 | MP0004043_abnormal_pH_regulation | 0.86959296 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.85045623 |
| 77 | MP0003724_increased_susceptibility_to | 0.83251701 |
| 78 | MP0009745_abnormal_behavioral_response | 0.82344485 |
| 79 | MP0003252_abnormal_bile_duct | 0.81830573 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.81456354 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.80347621 |
| 82 | MP0003786_premature_aging | 0.80245648 |
| 83 | MP0009764_decreased_sensitivity_to | 0.79509156 |
| 84 | MP0006054_spinal_hemorrhage | 0.78953052 |
| 85 | MP0005165_increased_susceptibility_to | 0.78702106 |
| 86 | MP0006072_abnormal_retinal_apoptosis | 0.76622582 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.76421445 |
| 88 | MP0005253_abnormal_eye_physiology | 0.74860950 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.71856613 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.70636340 |
| 91 | MP0003075_altered_response_to | 0.70088783 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.69232628 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68074520 |
| 94 | MP0002933_joint_inflammation | 0.67783069 |
| 95 | MP0005503_abnormal_tendon_morphology | 0.67117737 |
| 96 | MP0002733_abnormal_thermal_nociception | 0.67054685 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.64067641 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.63590609 |
| 99 | MP0003195_calcinosis | 0.63562358 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.63293068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.88294064 |
| 2 | IgG deficiency (HP:0004315) | 5.71311332 |
| 3 | Agammaglobulinemia (HP:0004432) | 5.36531347 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.10582239 |
| 5 | Aplastic anemia (HP:0001915) | 5.03402548 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.49654010 |
| 7 | Hypoproteinemia (HP:0003075) | 3.89710306 |
| 8 | Thyroiditis (HP:0100646) | 3.86500671 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.82392072 |
| 10 | Abnormality of T cells (HP:0002843) | 3.74576426 |
| 11 | Cerebral palsy (HP:0100021) | 3.56451047 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51440730 |
| 13 | Abnormality of eosinophils (HP:0001879) | 3.50558194 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46831563 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46831563 |
| 16 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.45814827 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.42967083 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.42967083 |
| 19 | Combined immunodeficiency (HP:0005387) | 3.36736305 |
| 20 | Increased intramyocellular lipid droplets (HP:0012240) | 3.31166905 |
| 21 | Hemiplegia (HP:0002301) | 3.26500144 |
| 22 | Meningitis (HP:0001287) | 3.23602996 |
| 23 | Hypoplasia of the thymus (HP:0000778) | 3.18054808 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.09486676 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.06665497 |
| 26 | Encephalitis (HP:0002383) | 2.98804080 |
| 27 | B lymphocytopenia (HP:0010976) | 2.95397696 |
| 28 | Generalized aminoaciduria (HP:0002909) | 2.90613583 |
| 29 | Increased IgM level (HP:0003496) | 2.89839730 |
| 30 | Eosinophilia (HP:0001880) | 2.89636747 |
| 31 | Hepatocellular necrosis (HP:0001404) | 2.82235422 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80147924 |
| 33 | Increased muscle lipid content (HP:0009058) | 2.72132919 |
| 34 | Recurrent viral infections (HP:0004429) | 2.69610835 |
| 35 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64032142 |
| 36 | Hepatic necrosis (HP:0002605) | 2.58538303 |
| 37 | Abnormality of B cell number (HP:0010975) | 2.57282388 |
| 38 | Increased serum ferritin (HP:0003281) | 2.54321260 |
| 39 | Methylmalonic acidemia (HP:0002912) | 2.51419794 |
| 40 | Leukocytosis (HP:0001974) | 2.45400280 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44600402 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.44584746 |
| 43 | Lymphopenia (HP:0001888) | 2.41437018 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.35285019 |
| 45 | Methylmalonic aciduria (HP:0012120) | 2.33751654 |
| 46 | IgM deficiency (HP:0002850) | 2.32317952 |
| 47 | Recurrent skin infections (HP:0001581) | 2.31943692 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.31335682 |
| 49 | Decreased central vision (HP:0007663) | 2.31165923 |
| 50 | Increased IgE level (HP:0003212) | 2.30952204 |
| 51 | Granulocytopenia (HP:0001913) | 2.27713747 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.27081839 |
| 53 | Tetraplegia (HP:0002445) | 2.26338421 |
| 54 | Chronic diarrhea (HP:0002028) | 2.25951637 |
| 55 | Bronchitis (HP:0012387) | 2.25468010 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.24059773 |
| 57 | 3-Methylglutaconic aciduria (HP:0003535) | 2.23999749 |
| 58 | Pancytopenia (HP:0001876) | 2.22712064 |
| 59 | Stomatitis (HP:0010280) | 2.20559866 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.19637116 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.17010925 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.14886115 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.12791139 |
| 64 | Lymphoma (HP:0002665) | 2.10868837 |
| 65 | Attenuation of retinal blood vessels (HP:0007843) | 2.09957490 |
| 66 | Spastic paraparesis (HP:0002313) | 2.09832430 |
| 67 | Chronic sinusitis (HP:0011109) | 2.08468505 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08350832 |
| 69 | Acute hepatic failure (HP:0006554) | 2.08150168 |
| 70 | Conical tooth (HP:0000698) | 2.07303344 |
| 71 | Obstructive lung disease (HP:0006536) | 2.06057974 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06057974 |
| 73 | Renal cortical cysts (HP:0000803) | 2.05760432 |
| 74 | Papilloma (HP:0012740) | 2.04952790 |
| 75 | Verrucae (HP:0200043) | 2.04952790 |
| 76 | Sepsis (HP:0100806) | 2.04476107 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03355135 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.02406112 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02406112 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 1.99377792 |
| 81 | Failure to thrive in infancy (HP:0001531) | 1.99277002 |
| 82 | Rhabdomyolysis (HP:0003201) | 1.95295916 |
| 83 | Abnormal albumin level (HP:0012116) | 1.95110620 |
| 84 | Hypoalbuminemia (HP:0003073) | 1.95110620 |
| 85 | Alveolar cell carcinoma (HP:0006519) | 1.94099816 |
| 86 | Pustule (HP:0200039) | 1.94073559 |
| 87 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93314644 |
| 88 | Mesangial abnormality (HP:0001966) | 1.92971547 |
| 89 | Exercise-induced myalgia (HP:0003738) | 1.87888915 |
| 90 | Palpebral edema (HP:0100540) | 1.87681529 |
| 91 | Cerebral edema (HP:0002181) | 1.86983880 |
| 92 | Periorbital edema (HP:0100539) | 1.86215615 |
| 93 | Pancreatitis (HP:0001733) | 1.86111648 |
| 94 | Radial bowing (HP:0002986) | 1.85909218 |
| 95 | Skin rash (HP:0000988) | 1.85500721 |
| 96 | Inflammation of the large intestine (HP:0002037) | 1.85368647 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.85022173 |
| 98 | Progressive microcephaly (HP:0000253) | 1.84961014 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.83683723 |
| 100 | Cerebral hypomyelination (HP:0006808) | 1.83661640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.00067552 |
| 2 | TESK2 | 4.93668814 |
| 3 | KDR | 4.56539072 |
| 4 | TXK | 4.20648074 |
| 5 | VRK2 | 2.98454222 |
| 6 | MAP3K11 | 2.94626885 |
| 7 | FES | 2.88878926 |
| 8 | LIMK1 | 2.81132358 |
| 9 | MAP4K1 | 2.37728395 |
| 10 | GRK6 | 2.35213951 |
| 11 | TESK1 | 2.30791188 |
| 12 | SCYL2 | 2.23347330 |
| 13 | MAP3K12 | 1.87997933 |
| 14 | TNK2 | 1.84320176 |
| 15 | MAPKAPK3 | 1.73752938 |
| 16 | ITK | 1.58946583 |
| 17 | KIT | 1.51752889 |
| 18 | NME2 | 1.38861292 |
| 19 | PINK1 | 1.37974941 |
| 20 | TYRO3 | 1.35223525 |
| 21 | TBK1 | 1.31991454 |
| 22 | LCK | 1.31021529 |
| 23 | SYK | 1.28572456 |
| 24 | ADRBK2 | 1.26988986 |
| 25 | PRKCQ | 1.26852510 |
| 26 | TLK1 | 1.22036539 |
| 27 | IKBKE | 1.18106509 |
| 28 | NUAK1 | 1.13375902 |
| 29 | IKBKB | 1.12914795 |
| 30 | BMPR2 | 1.11419055 |
| 31 | PIM2 | 1.09775813 |
| 32 | NME1 | 1.04713677 |
| 33 | DAPK2 | 1.01679138 |
| 34 | PIM1 | 1.00726587 |
| 35 | CSNK1G3 | 1.00514461 |
| 36 | VRK1 | 0.98807055 |
| 37 | ARAF | 0.98328212 |
| 38 | CSF1R | 0.98222325 |
| 39 | CSK | 0.98170154 |
| 40 | GRK1 | 0.97972662 |
| 41 | DAPK1 | 0.94906752 |
| 42 | BUB1 | 0.93741115 |
| 43 | MAPK11 | 0.90984278 |
| 44 | WNK4 | 0.90103948 |
| 45 | LYN | 0.88948193 |
| 46 | CCNB1 | 0.88469630 |
| 47 | GRK7 | 0.84862426 |
| 48 | BLK | 0.84595560 |
| 49 | PHKG2 | 0.76802988 |
| 50 | PHKG1 | 0.76802988 |
| 51 | CSNK1A1L | 0.76246171 |
| 52 | CSNK1G1 | 0.73226398 |
| 53 | CSNK1G2 | 0.71027970 |
| 54 | MAP2K7 | 0.67813165 |
| 55 | TAOK3 | 0.67018253 |
| 56 | RPS6KA4 | 0.66150952 |
| 57 | TEC | 0.65782868 |
| 58 | MAPKAPK2 | 0.63754808 |
| 59 | MAPK13 | 0.61344822 |
| 60 | AURKA | 0.61212775 |
| 61 | BTK | 0.60615192 |
| 62 | CSNK1A1 | 0.60543616 |
| 63 | FYN | 0.55841844 |
| 64 | CAMK2A | 0.53043194 |
| 65 | PIK3CG | 0.52402588 |
| 66 | TIE1 | 0.51258105 |
| 67 | JAK3 | 0.50018033 |
| 68 | RPS6KA5 | 0.49778636 |
| 69 | ILK | 0.48159644 |
| 70 | ZAP70 | 0.48038200 |
| 71 | MAP2K2 | 0.47636339 |
| 72 | CAMK2G | 0.47419263 |
| 73 | DAPK3 | 0.47068470 |
| 74 | TAOK2 | 0.45651909 |
| 75 | MYLK | 0.45630009 |
| 76 | LMTK2 | 0.45538802 |
| 77 | MAP3K1 | 0.45210324 |
| 78 | OBSCN | 0.43893698 |
| 79 | MINK1 | 0.43754138 |
| 80 | MAP4K2 | 0.43407972 |
| 81 | CHUK | 0.41448812 |
| 82 | ABL1 | 0.41244977 |
| 83 | IGF1R | 0.40771098 |
| 84 | MAP3K14 | 0.39694389 |
| 85 | PRKCA | 0.32749369 |
| 86 | MAP3K5 | 0.30606994 |
| 87 | ABL2 | 0.30394225 |
| 88 | JAK1 | 0.30210880 |
| 89 | INSR | 0.29981945 |
| 90 | CAMKK2 | 0.28287022 |
| 91 | INSRR | 0.27905146 |
| 92 | PRKACA | 0.27763989 |
| 93 | MAPK7 | 0.26845576 |
| 94 | CSNK1D | 0.26707720 |
| 95 | PIK3CA | 0.24591886 |
| 96 | NTRK2 | 0.24154610 |
| 97 | PTK2B | 0.23934266 |
| 98 | MST4 | 0.23356304 |
| 99 | MAP2K3 | 0.23323530 |
| 100 | LATS1 | 0.23014203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.47598845 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.80163817 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.67222660 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.50337976 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.46420176 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.12878619 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.79491974 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.76840468 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.48624514 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.46656641 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16220174 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.15949537 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12375767 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.02368757 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95713245 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79934325 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.77364161 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.63690292 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61308701 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.46143230 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40157092 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.36994131 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35232618 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.32889471 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.23428765 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.21656582 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19005581 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17588777 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11427566 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10421722 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98573271 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94389319 |
| 33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86904667 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83570580 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82597480 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81760318 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81557800 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76752732 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75913101 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 0.73885007 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72114405 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71020398 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70386380 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69395776 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68248524 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66653687 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65556663 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64285950 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62518003 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62264460 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.61975135 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.61764525 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.60061468 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58983610 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58926021 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58366394 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58347033 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57668525 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57464547 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.57131481 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53944989 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51403646 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51254381 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51105710 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.50468310 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49029504 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.48675978 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48298190 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.48250587 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.47536769 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45175807 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.44640509 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.44532279 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.43337164 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41184204 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40723143 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39118336 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.38950764 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.37594536 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36037806 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34292865 |
| 82 | Ribosome_Homo sapiens_hsa03010 | 0.33620390 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32688413 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32596908 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.31458855 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31077750 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.30158127 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29261727 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29129848 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29050898 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28851650 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.27507687 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.27227899 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24531133 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23788905 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23177274 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.23159688 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19092837 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.17784635 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.16951566 |

